Khan, M.U.; Jabeen, I.; Althagafi, A.; Farooq, M.U.; Harb, M.; Arkook, B.
DFT and Molecular Docking Study of HA-Conjugated SWCNTs for CD44-Targeted Delivery of Platinum-Based Chemotherapeutics. Pharmaceuticals 2025, 18, 805.
https://doi.org/10.3390/ph18060805
AMA Style
Khan MU, Jabeen I, Althagafi A, Farooq MU, Harb M, Arkook B.
DFT and Molecular Docking Study of HA-Conjugated SWCNTs for CD44-Targeted Delivery of Platinum-Based Chemotherapeutics. Pharmaceuticals. 2025; 18(6):805.
https://doi.org/10.3390/ph18060805
Chicago/Turabian Style
Khan, Muhammad Uzair, Ishrat Jabeen, Abdulhamid Althagafi, Muhammad Umar Farooq, Moussab Harb, and Bassim Arkook.
2025. "DFT and Molecular Docking Study of HA-Conjugated SWCNTs for CD44-Targeted Delivery of Platinum-Based Chemotherapeutics" Pharmaceuticals 18, no. 6: 805.
https://doi.org/10.3390/ph18060805
APA Style
Khan, M. U., Jabeen, I., Althagafi, A., Farooq, M. U., Harb, M., & Arkook, B.
(2025). DFT and Molecular Docking Study of HA-Conjugated SWCNTs for CD44-Targeted Delivery of Platinum-Based Chemotherapeutics. Pharmaceuticals, 18(6), 805.
https://doi.org/10.3390/ph18060805